| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Summit Therapeutics Inc. (SMMT) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 5 sells. SMMT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 573.88M | $7.77B | - | |
| CEO | 25.82M | $349.66M | - | |
| CFO | 3.07M | $41.62M | - | |
| Dir | 35.0K | $473.9K | - | |
| Dir | 35.0K | $473.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2020 | Powell David Jonathan | Chief Scientific Officer | Sale+OE | 43,282 | $4.41 | $190,693.63 | -100% | |
| Nov 25, 2020 | Powell David Jonathan | Chief Scientific Officer | Sale+OE | 30,431 | $4.30 | $130,769.74 | -100% | |
| Nov 6, 2020 | Duggan Robert W76 | Chief Executive Officer | Buy | 14,071,856 | $3.34 | $46,999,999.04 | +33.3% |